Streetbeat News

Analyst Ratings

ALIM

Alimera Sciences' stock has been upgraded from Neutral to Buy by Alliance Global Partners, with the price target raised from $4.5 to $8.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:20 pm

VNT

Citigroup analyst Andrew Kaplowitz maintains a Buy rating on Vontier (NYSE:VNT) and raises the price target from $33 to $36.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:18 pm

USB

U.S. Bancorp shares are trading lower after Citigroup maintained a Neutral rating on the stock and lowered its price target from $39 to $33.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 4:17 pm

ORCL

Wolfe Research analyst Ryan Krieger upgraded Oracle Corp (NYSE:ORCL) to Outperform from Peer Perform with a price target of $130, citing strong growth in Oracle Cloud Infrastructure (OCI) adoption and AI acceleration. Krieger expects OCI revenues to grow significantly and Oracle's market share to double by 2025. Evercore ISI Group also increased Oracle's price target to $110 from $95.

Portfolio Pulse from Lekha Gupta

June 12, 2023 | 4:02 pm

GLPG

Galapagos (NASDAQ:GLPG) has received 1 somewhat bullish and 4 indifferent analyst ratings in the last quarter, with an average price target of $47.8, implying an upside from the current price of $42.44. The average price target has increased by 3.17% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 4:02 pm

ILMN

In the last quarter, Illumina (NASDAQ:ILMN) received 2 bullish, 2 somewhat bullish, and 1 indifferent rating from analysts. The average 12-month price target for the stock is $285.6, with a high of $334 and a low of $229. The average price target has increased by 3.95% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 4:02 pm

RETA

Over the past 3 months, 4 analysts have published their opinion on Reata Pharmaceuticals (NASDAQ:RETA) stock, with 1 bullish and 3 somewhat bullish ratings. The company has an average 12-month price target of $116.5, which has increased by 17.68% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 4:01 pm

CFLT

Over the past 3 months, 14 analysts have published their opinions on Confluent (NASDAQ:CFLT) stock, with an average 12-month price target of $30.71, up 2.06% from the previous average of $30.09. The ratings include 3 bullish, 8 somewhat bullish, and 3 indifferent.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 4:01 pm

ASH

In the last 3 months, 8 analysts have provided 12-month price targets for Ashland (NYSE:ASH), with an average target of $118.25, down 6.37% from the previous average of $126.29. The majority of ratings are bullish.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 4:00 pm

LII

KeyBanc Capital Markets analyst Jeffrey D. Hammond upgraded Lennox International, Inc. (NYSE:LII) to Overweight from Sector Weight, with a price target of $355. The upgrade is based on the company's strategic pricing, distribution focus, and growth prospects.

Portfolio Pulse from Nabaparna Bhattacharya

June 12, 2023 | 3:57 pm